Article Details
Retrieved on: 2020-12-15 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... lifting the lid on phase 3 data from its potential challenger to <b>Roche</b> in chronic lymphocytic leukaemia (CLL). The New York-based biotech requested ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here